Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children

Background and ObjectiveModel validation procedures are crucial when models are to be used to develop new dosing algorithms. In this study, the predictive performance of a previously published paediatric population pharmacokinetic model for morphine and its metabolites in children younger than 3 years (original model) is studied in new datasets that were not used to develop the original model.MethodsSix external datasets including neonates and infants up to 1 year were obtained from four different research centres. These datasets contained postoperative patients, ventilated patients and patients on extracorporeal membrane oxygenation (ECMO) treatment. Basic observed versus predicted plots, normalized prediction distribution error analysis, model refitting, bootstrap analysis, subpopulation analysis and a literature comparison of clearance predictions were performed with the new datasets to evaluate the predictive performance of the original morphine pharmacokinetic model.ResultsThe original model was found to be stable and the parameter estimates were found to be precise. The concentrations predicted by the original model were in good agreement with the observed concentrations in the four datasets from postoperative and ventilated patients, and the model-predicted clearances in these datasets were in agreement with literature values. In the datasets from patients on ECMO treatment with continuous venovenous haemofiltration (CVVH) the predictive performance of the model was good as well, whereas underprediction occurred, particularly for the metabolites, in patients on ECMO treatment without CVVH.ConclusionThe predictive value of the original morphine pharmacokinetic model is demonstrated in new datasets by the use of six different validation and evaluation tools. It is herewith justified to undertake a proof-of-principle approach in the development of rational dosing recommendations — namely, performing a prospective clinical trial in which the model-based dosing algorithm is clinically evaluated.

[1]  D. Tibboel,et al.  Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. , 2007, British journal of anaesthesia.

[2]  D. Tibboel,et al.  Efficacy of continuous versus intermittent morphine administration after major surgery in 0–3-year-old infants; a double-blind randomized controlled trial , 2002, Pain.

[3]  D. Tibboel,et al.  Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years , 2009, Clinical pharmacokinetics.

[4]  Dick Tibboel,et al.  Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. , 2003, JAMA.

[5]  H. Mulla,et al.  Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. , 2005, British journal of clinical pharmacology.

[6]  Imti Choonara,et al.  Morphine metabolism in neonates and infants. , 1992 .

[7]  M. Levene,et al.  Pharmacokinetics of morphine infusion in premature neonates. , 1993, Archives of disease in childhood.

[8]  M. Buck.  Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation , 2003, Clinical pharmacokinetics.

[9]  E. Niclas Jonsson,et al.  Erratum to "PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM" [Comput. Methods Prog. Biomedicine 79 (2005) 241-257] , 2005, Comput. Methods Programs Biomed..

[10]  K. Olkkola,et al.  Kinetics and dynamics of postoperative intravenous morphine in children , 1988 .

[11]  V. Fellman,et al.  Morphine clearance and effects in newborn infants in relation to gestational age , 2000, Clinical pharmacology and therapeutics.

[12]  C. Knibbe,et al.  Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children , 2009, European Journal of Clinical Pharmacology.

[13]  I. Choonara,et al.  Morphine sulphation in children. , 1990, British journal of clinical pharmacology.

[14]  A. Merry,et al.  Data sharing for pharmacokinetic studies , 2009, Paediatric anaesthesia.

[15]  D. Tibboel,et al.  Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study , 2009, Critical care.

[16]  H. Leufkens,et al.  Off-label use of medicines in children: can available evidence avoid useless paediatric trials? , 2009, European Journal of Clinical Pharmacology.

[17]  S. Bratton,et al.  Clearance of Morphine in Postoperative Infants During Intravenous Infusion: The Influence of Age and Surgery , 1998, Anesthesia and analgesia.

[18]  T. Seppälä,et al.  Age-related morphine kinetics in infants. , 1993, Developmental pharmacology and therapeutics.

[19]  N. Holford,et al.  Population clinical pharmacology of children: modelling covariate effects , 2006, European Journal of Pediatrics.

[20]  N. Rutter,et al.  Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. , 2003, British journal of clinical pharmacology.

[21]  E. Niclas Jonsson,et al.  PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..

[22]  H. Mulla,et al.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation. , 2003, British journal of clinical pharmacology.

[23]  M. Hanekamp.  Short and Long Term Studies in Neonates treated with Extracorporeal Membrane Oxygenation (ECMO) , 2005 .

[24]  Kelly L. Lundstrom,et al.  Morphine pharmacokinetics in premature and mature newborn infants , 1994, Acta paediatrica.

[25]  K. Craig,et al.  Morphine pharmacokinetics and pain assessment in premature newborns. , 1999, The Journal of pediatrics.

[26]  Michel Tod,et al.  Facilitation of Drug Evaluation in Children by Population Methods and Modelling , 2008, Clinical pharmacokinetics.

[27]  D. Tibboel,et al.  Morphine Metabolite Pharmacokinetics during Venoarterial Extra Corporeal Membrane Oxygenation in Neonates , 2006, Clinical pharmacokinetics.

[28]  S. Bratton,et al.  Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions , 2000, Pain.

[29]  Graham Lawson,et al.  Pharmacokinetics of Midazolam in Neonates Undergoing Extracorporeal Membrane Oxygenation , 2003, Anesthesiology.

[30]  K. Anand,et al.  Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. , 2008, British journal of anaesthesia.

[31]  France Mentré,et al.  Are Population Pharmacokinetic and/ or Pharmacodynamic Models Adequately Evaluated? , 2007, Clinical pharmacokinetics.

[32]  J. Slattery,et al.  The maturation of morphine clearance and metabolism. , 1992, American journal of diseases of children.

[33]  Meindert Danhof,et al.  Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. , 2009, Drug discovery today.

[34]  Paul Chay,et al.  Pharmacokinetic‐pharmacodynamic relationships of morphine in neonates , 1992, Clinical pharmacology and therapeutics.

[35]  France Mentré,et al.  Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R , 2008, Comput. Methods Programs Biomed..

[36]  R. Lingen.  Pain Assessment and Analgesia in the Newborn: An Integrated Approach , 2000 .

[37]  D. Tibboel,et al.  Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. , 2004, British journal of anaesthesia.

[38]  D. Tibboel,et al.  Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates , 2005, Intensive Care Medicine.

[39]  France Mentré,et al.  Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide , 2006, Pharmaceutical Research.